Synthesize Bio logo

Synthesize Bio

synthesize.bio

Synthesize Bio develops generative genomics models that predict how human tissues and cells respond to drugs, diseases, and experimental interventions. Its platform enables drug development teams, clinical development teams, and biopharma partners to simulate clinical trial outcomes, optimize trial design, identify biomarkers, and augment limited datasets with virtual human cohorts. The organization aims to accelerate and de-risk clinical development by providing actionable predictions and insights grounded in large-scale RNA-seq data.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Founded
2023
Type
Corporation Seattle business license
Employees
21
Registered name
Synthesize Bio Seattle business license
Stage
Seed
Founders
Robert Bradley, PhD, Jeff Leek, PhD

Is this your organization? Claim it

Founders

Executives

  • Alice M. Walsh Executive, COO

Online